NexGel, Inc. (NXGL)
0.174
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
0.1664
-0.01
(-4.37%)
After-Hours: 20:00
NexGel EPS Diluted (Quarterly) : -0.4033 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4033 |
| March 31, 2026 | -0.113 |
| December 31, 2025 | -0.1191 |
| September 30, 2025 | -0.0819 |
| June 30, 2025 | -0.0869 |
| March 31, 2025 | -0.0931 |
| December 31, 2024 | -0.1164 |
| September 30, 2024 | -0.1055 |
| June 30, 2024 | -0.1415 |
| March 31, 2024 | -0.1426 |
| December 31, 2023 | -0.1912 |
| September 30, 2023 | -0.0962 |
| June 30, 2023 | -0.1227 |
| March 31, 2023 | -0.1445 |
| December 31, 2022 | -0.1162 |
| September 30, 2022 | -0.2202 |
| Date | Value |
|---|---|
| June 30, 2022 | -0.1857 |
| March 31, 2022 | -0.3295 |
| December 31, 2021 | -0.2941 |
| September 30, 2021 | -0.011 |
| June 30, 2021 | -0.008 |
| March 31, 2021 | -0.007 |
| December 31, 2020 | -0.0065 |
| September 30, 2020 | -0.0052 |
| June 30, 2020 | -0.0051 |
| March 31, 2020 | -0.0049 |
| December 31, 2019 | -0.0054 |
| September 30, 2019 | 0.0129 |
| June 30, 2019 | -0.0103 |
| March 31, 2019 | -0.0059 |
| December 31, 2018 | -0.0115 |
| September 30, 2018 | -0.1506 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| IDEXX Laboratories, Inc. | 4.267 |
| Neogen Corp. | -0.0519 |
| QuidelOrtho Corp. | -1.360 |
| Aspira Women's Health, Inc. | -0.0547 |
| Biomerica, Inc. | -0.3729 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.606M |
| Revenue (Quarterly) | 3.686M |
| Total Expenses (Quarterly) | 7.321M |
| Enterprise Value | 7.957M |
| Gross Profit Margin (Quarterly) | 30.09% |
| Profit Margin (Quarterly) | -97.83% |
| Earnings Yield | -412.2% |
| Normalized Earnings Yield | -458.22 |